首页> 外文期刊>Applied health economics and health policy >Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage
【24h】

Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage

机译:在扩大医疗保健覆盖范围内的国家塑造药物招标

获取原文
获取原文并翻译 | 示例
           

摘要

Policy makers in countries, aiming to build and expand their healthcare systems and coverage, need effective procedures to support the most efficient use of limited financial resources. Tendering is commonly deployed to minimize and fix the purchasing price for the contract duration, especially for off-patent Pharmaceuticals. While tenders can reduce acquisition costs, they may also expose the healthcare systems to risks including drug shortages, quality trade-offs, and ultimately, compromised patient health outcomes. Careful planning is therefore required. The effectiveness and impact of tendering were examined in different healthcare settings to establish good tender practices and to develop guidance for tender stakeholders in countries with expanding healthcare coverage for the effective conduct. The literature was reviewed for tender practices and outcomes in all countries, and tender experts from one multi-national pharmaceutical company in 17 countries with expanding healthcare coverage were surveyed on current tender practices. Tendering is a common practice for multisource Pharmaceuticals in most countries worldwide. However, countries with expanding healthcare coverage specifically are vulnerable to the risks of defective tendering practices. Risk factors include non-transparent tender practices, a lack of consistency, unclear tender award criteria, a focus on lowest price only, single-winner tendering, and generally, a lack of impact monitoring. If well planned, managed, and conducted, tenders can be advantageous. Countries with expanding healthcare coverage should approach tenders strategically to achieve the desired improvements in healthcare. The good tender practices derived from this study may guide policy makers and purchasers in countries with expanding healthcare coverage on how to expand access to healthcare at an affordable cost. These include the use of multiple selection criteria and performance monitoring.
机译:国家的决策者,旨在建立和扩大医疗保健系统和覆盖,需要有效的程序来支持最有效地利用有限的财政资源。通常部署招标,以最大限度地减少和修复合同持续时间的购买价格,尤其是用于非专利药物。虽然招标可以减少收购成本,但它们也可能将医疗保健系统暴露给包括毒品短缺,质量权衡,最终损害的患者健康结果的风险。因此需要仔细规划。在不同的医疗保健环境中检查了招标的有效性和影响,以建立良好的招标实践,并为有效行为扩大医疗保健覆盖的国家的招标利益攸关方制定指导。该文献在所有国家的招标实践和结果审查,并在目前的招标实践上调查了17个国家的17个国家的一家多国制药公司的招标专家。招标是全球大多数国家的多源药品的常见做法。但是,具有扩展医疗保健覆盖的国家特别容易受到造型招标实践的风险。危险因素包括非透明招标实践,缺乏一致性,不明确的招标标准,专注于最低价格,单胜人招标,一般缺乏影响监测。如果良好的计划,管理和进行,招标可能是有利的。扩大医疗保健覆盖范围的国家应战略性地接近招标,以达到医疗保健的预期改进。来自本研究的良好招标实践可以指导在以经济实惠的成本扩大医疗保健覆盖的国家的政策制定者和购买者以实惠的成本扩大医疗保健。这些包括使用多种选择标准和性能监控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号